CDC COCA Call: Testing and Treatment of 2020-2021 Seasonal Influenza During the COVID-19 Pandemic
Influenza surveillance data reported to the World Health Organization’s FluNet platform from three Southern Hemisphere countries (Australia, Chile, and South Africa) indicated low influenza activity during June through August 2020, months that comprise the typical Southern Hemisphere influenza season. The low influenza activity observed in the Southern Hemisphere might reflect the impact of non-pharmaceutical interventions implemented to reduce the spread of SARS-CoV-2, the virus that causes COVID-19. However, it is not possible to predict influenza activity or the severity of the upcoming influenza season in the United States with the potential for co-circulation of influenza viruses and SARS-CoV-2. While vaccination remains the best way to prevent influenza, antiviral medications are an essential adjunct to vaccination—especially for treating outpatients with suspected or confirmed influenza, in persons at high risk for influenza complications, in those with progressive disease, and hospitalized influenza patients.
During this COCA call, clinicians will hear an overview of CDC’s recommendations for health care providers regarding influenza diagnostics and the use of antiviral medications for the 2020-2021 influenza season, including considerations during the ongoing COVID-19 pandemic.
If you are unable to attend the live COCA call, the recording and slide set will be available for viewing on the COCA Call webpage a few hours after the live event.
Free Continuing Education (CE) will be offered for this COCA Call.
Please see call information below:
Date: Thursday, September 17, 2020
Time: 1:00-2:00 pm (CST)
Webinar link: https://www.zoomgov.com/j/1604984692
Phone: 1-669-254-5252 or 1-646-828-7666
Webinar ID: 160 498 4692
|
